Skip to main content
Clinical Trials/NL-OMON31867
NL-OMON31867
Not Yet Recruiting
N/A

Evaluation of the cognitive and psychomotor effects of LY2624803 following bedtime dosing in healthy subjects - Evaluation of CNS effects of LY2624803 following bedtime dosing

Eli Lilly0 sites40 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
insomnia
Sponsor
Eli Lilly
Enrollment
40
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Sponsor
Eli Lilly

Eligibility Criteria

Inclusion Criteria

  • 1\. Provision of written informed consent
  • 2\. Healthy male and female subjects aged 18 to 45 years or 65\-85 years on sceening
  • 3\. Body Mass Index (BMI) \>\= 19 and \<\= 30 kg/m2

Exclusion Criteria

  • 1\.Investigator site personnel or Lilly employees directly affiliated with this study
  • and their immediate families. Immediate family is defined as a spouse, parent,
  • child or sibling, whether biological or legally adopted.
  • 2\.Shift workers (those who shifted work within 7 days of any study night) or any
  • person who has crossed (or will have crossed) more than one time zone by aircraft
  • within 3 days prior to each study night.
  • 3\.Rhinoconjunctivitis, urticaria, chronic pain or nocturia that, in the investigator\*s
  • opinion, would interfere with sleep assessment.
  • 4\.Previously diagnosed sleep disorder including chronic insomnia, sleep apnea,
  • narcolepsy or restless leg syndrome, or current symptoms consistent with a sleep

Outcomes

Primary Outcomes

Not specified

Similar Trials